Coherus: Interchangeability ‘A Melting Ice Cube,’ Price And Supply Key
FDA-Approved Yusimry Biosimilar Device ‘Will Look Nearly Identical’
Coherus’ manufacturing scale for its Yusimry adalimumab biosimilar means it will “be able to drive the price down and to be able to provide supply guarantees,” management has insisted during a recent investor conference. “We think this will be very, very important.”
